Endocrine Society Partners with Keystone Symposia to Advance Research and Education

The Endocrine Society and Keystone Symposia, a nonprofit host of conferences and symposia on a range of life science and biomedical topics, will jointly host a series of three conferences to advance endocrine research. 

The three conferences will focus on diabetes, oncology, and cardiovascular disease — hormone-related conditions that have a major impact on public health. The conference series is slated to launch in late 2026 or early 2027 and will run for at least three years. 

Each event will feature the top-flight scientific programming and luminary speakers both organizations are known for. The conferences are designed to accelerate scientific breakthroughs, catalyzing advances in foundational science that can ultimately lead to improved clinical outcomes for patients.  

“We are elated about the opportunity to collaborate with Keystone Symposia in the spirit of advancing science,” says Endocrine Society President John Newell-Price MD, PhD, FRCP. “Our basic research members value the opportunity to discuss science with other leading members of the field, and this series of conferences will offer more chances for basic researchers to interact and share ideas.” 

Keystone Symposia specializes in holding intimate conferences in relaxed environments that encourage networking and fosters connections among attendees. Building relationships with other researchers can inspire scientists to pursue new lines of inquiry and form partnerships, which can advance discoveries. 

“This partnership will be instrumental in bringing together basic scientists with clinicians and clinician-scientists to accelerate translational advances that will impact patients. We are thrilled to connect with the Endocrine Society to facilitate this common goal,” states Keystone Symposia President & CEO James Baumgartner, PhD. “These conferences will spur innovative perspectives and collaborations that integrate laboratory research with clinical insights, to ultimately yield breakthroughs against three of the most deadly diseases we face in modern society– cardiovascular disease, diabetes and cancer.” 

The Endocrine Society and Keystone Symposia plan to hold the conferences annually for at least three years.  

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in